Antònia Agustí

Universitat Autònoma de Barcelona (UAB)

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Moises Labrador-Horrillo

Profesor Titular

University of Barcelona

SPAIN

View details

Jaume Mestre Torres

Associate Professor.

Universitat Autònoma de Barcelona Facultat de Medicina

SPAIN

View details

Caridad Pontes

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Oleguer Parés-Badell

Assistant professor

University of Barcelona

SPAIN

View details

Imma Danés

Head of Section

Hospital Universitari Vall d'Hebron

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antònia Agustí

Research Interests

Explore related searches

Contact this professor

Articles (16)

Delabelling beta-lactam allergy

Challenging dogmas :

Clinical pharmacology facing the real-world setting: pharmacovigilance, pharmacoepidemiology and the economic evaluation of drugs

The challenges of access to innovative medicines with limited evidence in the European Union.

Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, followup, and contribution to the pharmacovigilance system.

Financing and reimbursement of approved advanced therapies in several European countries.

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review

Fármacos modificadores de la enfermedad en la esclerosis múltiple durante la lactancia:

Regulatory and clinical development to support the approval of advanced therapies medicinal products in Japan

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination

Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study

Review on the management of cardiovascular risk factors in the elderly.

Management of Cancer-Associated Myositis

Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection

Spontaneously Reported Adverse Drug Reactions and Their Description in Hospital Discharge Reports: A Retrospective Study

Withdrawal of hospital outpatient treatments in severe diseases due to unacceptable toxicity: A retrospective study from the register of patients and treatments

Collaborators (5)

Moises Labrador-Horrillo

Jaume Mestre Torres

Caridad Pontes

Oleguer Parés-Badell

Imma Danés

Make your next move.